Showing results (121-130 of 140) with videos related to
Sort By:
Pageof 14
The New England Journal of Medicine|April 13, 2022
Mitapivat versus Placebo for Pyruvate Kinase DeficiencyHanny Al-Samkari, Frédéric Galactéros, Andreas Glenthøj, et al.Pediatric Blood & Cancer|June 14, 2021
Pyruvate kinase deficiency in childrenSatheesh Chonat, Stefan W Eber, Susanne Holzhauer, et al.Blood Advances|February 5, 2026
Multicenter initiative to standardize management of pediatric immune thrombocytopenia improves adherence to guidelinesElizabeth Gunn, Pablo A Angulo, Sherif M Badawy, et al.Blood Advances|August 27, 2024
Genetic variants in canonical Wnt signaling pathway associated with pediatric immune thrombocytopeniaTaylor Olmsted Kim, Jennifer M Geris, Jonathan M Flanagan, et al.Pediatric Blood & Cancer|June 16, 2011
Response to steroids predicts response to rituximab in pediatric chronic immune thrombocytopeniaRachael F Grace, Carolyn M Bennett, A Kim Ritchey, et al.Blood Advances|February 4, 2026
Guideline on the emergency management of critical bleeding in patients with immune thrombocytopeniaSaifur R Chowdhury, Emily Sirotich, Gordon H Guyatt, et al.The New England Journal of Medicine|September 5, 2019
Safety and Efficacy of Mitapivat in Pyruvate Kinase DeficiencyRachael F Grace, Christian Rose, D Mark Layton, et al.American Journal of Hematology|April 5, 2019
Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomesRachael F Grace, Kristin A Shimano, Rukhmi Bhat, et al.American Journal of Hematology|April 17, 2018
Physician decision making in selection of second-line treatments in immune thrombocytopenia in childrenRachael F Grace, Jenny M Despotovic, Carolyn M Bennett, et al.Journal of Thrombosis and Haemostasis : JTH|July 30, 2021
Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet ImmunologyEmily Sirotich, Gordon Guyatt, Caroline Gabe, et al.Pageof 14